Ventas Inc.

68.17
-0.24 (-0.35%)
At close: Apr 25, 2025, 3:59 PM
68.48
0.45%
After-hours: Apr 25, 2025, 06:05 PM EDT

Ventas Revenue Breakdown

Period Ending Sep 30, 2024 Jun 30, 2024 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Dec 31, 2011 Sep 30, 2011 Jun 30, 2011
Medical Office Building Operations Revenue 13.02M 8.63M 5.32M 4M 4.18M 790.78M 4.55M 4.33M 3.95M 3.92M 5.84M 5.38M 4.95M 804.15M 3.87M 3.67M 3.13M 2.96M 2.69M 2.52M 197.2M 194.37M 195.8M 193.98M 191.07M 188.09M 187.83M 186.32M 160.48M 147.46M 149.11M 155.47M 151.21M 148.15M 145.85M 126.13M 122.53M 117.61M 119.88M 117.42M 117.97M 113.11M 113.68M 110.5M 104.25M 95.2M 69.19M 101.12M 66.56M 33.58M
Medical Office Building Operations Revenue Growth +50.90% +62.33% +33.01% -4.33% -99.47% +17279.82% +5.18% +9.55% +0.64% -32.82% +8.55% +8.71% -99.38% +20689.79% +5.31% +17.42% +5.71% +9.96% +6.87% -98.72% +1.46% -0.73% +0.94% +1.52% +1.59% +0.14% +0.81% +16.10% +8.84% -1.11% -4.09% +2.81% +2.07% +1.58% +15.64% +2.93% +4.19% -1.89% +2.09% -0.47% +4.30% -0.51% +2.88% +5.99% +9.50% +37.59% -31.57% +51.92% +98.21% n/a

Revenue by Geography

Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Canada Revenue 464.77M 449.09M 434.86M 389.2M 266.95M 192.35M 186.05M 174.83M 173.78M 126.44M 93.22M 95.97M 92.04M
Canada Revenue Growth +3.49% +3.27% +11.73% +45.80% +38.78% +3.39% +6.42% +0.61% +37.44% +35.63% -2.87% +4.27% n/a
United Kingdom Revenue 28.88M 27.77M 29.95M 24.8M 3.58B 3.52B 26.42M 26.34M 26.17M 13.79M 2.72B 2.39B 1.67B
United Kingdom Revenue Growth +3.99% -7.26% +20.78% -99.31% +1.52% +13242.70% +0.30% +0.64% +89.82% -99.49% +13.71% +42.82% n/a
United States Revenue 4B 3.65B 3.36B 3.38B n/a n/a 3.36B 3.24B 3.09B 2.94B n/a n/a n/a
United States Revenue Growth +9.63% +8.60% -0.54% n/a n/a n/a +3.68% +5.05% +5.14% n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 41.43M 35.09M 37.73M 48.74M 36.38M 33.3M 34.4M 44.8M 33.54M 35.42M 32.91M 43M 28.6M 30.26M 30.59M 40.31M 29.54M 34.23M 29.98M 42.53M 41.63M 40.53M 43.08M 40.76M 38.48M 39.68M 36.66M 37.17M 34.93M 33.32M 33.28M 33.96M 31.49M 31.57M 32.09M 31.73M 27.64M 32.11M 33.96M 34.33M
Selling, General, and Administrative Revenue Growth +18.07% -6.98% -22.59% +33.96% +9.27% -3.20% -23.21% +33.57% -5.31% +7.61% -23.45% +50.33% -5.48% -1.08% -24.12% +36.47% -13.71% +14.15% -29.51% +2.18% +2.71% -5.92% +5.69% +5.94% -3.03% +8.24% -1.39% +6.42% +4.84% +0.11% -2.00% +7.85% -0.25% -1.64% +1.16% +14.80% -13.94% -5.44% -1.07% n/a
Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a